Taylor Wessing's focus is mirrored in the practice group management: Anja Lunze heads the life sciences segment, while Michael Stein is the key contact for the healthcare sector. Clients benefit from the close cooperation of the corporate, M&A and regulatory teams, where the team regularly supports buyers in transactions in the outpatient and inpatient sectors and in the formation of groups of medical care centers; the team also covers the procurement law interface, including advising hospital chains on the Hospital Future Act and the implementation of IT system, above all, hospital information systems. The focus in the life sciences area is on advising pharmaceutical and biotechnology companies on medical, pharmaceutical, patent and trademark law issues, including product liability and contentious matters. This is completed by capacities in the digital healthcare segment, where the regulatory team frequently cooperates with the TMT practice. Medical law expert Karolina Lange-Kulmann was appointed partner in April 2023, while Stefanie Greifeneder (regulatory, commercial and contract-related matters in the pharmaceutical, medical device and biotechnology sectors; compliance) joined the team the following month from Fieldfisher.
Testimonials
Collated independently by Legal 500 research team.
- 'The Taylor Wessing team has always been very responsive, well prepared and extremely professional.'
- 'Collaboration is always fair and based on transparency and a high level of accuracy.'
Key clients
- Amedes
- AstraZeneca
Work highlights
- Advising numerous financial investors and their portfolio companies (including amedes, NORD Holding, Oberberg, Sanecum and Trilantic) on various transactions in the inpatient and outpatient sectors, particularly with regard to the implementation of their respective buy-and-build strategies.
- Defending AstraZeneca against consumer lawsuits regarding its Covid-19 vaccine.